18-9117869-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000318388.11(NDUFV2):ā€‹c.86T>Cā€‹(p.Val29Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.811 in 1,595,082 control chromosomes in the GnomAD database, including 525,894 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.79 ( 47701 hom., cov: 32)
Exomes š‘“: 0.81 ( 478193 hom. )

Consequence

NDUFV2
ENST00000318388.11 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:9

Conservation

PhyloP100: 1.58
Variant links:
Genes affected
NDUFV2 (HGNC:7717): (NADH:ubiquinone oxidoreductase core subunit V2) The NADH-ubiquinone oxidoreductase complex (complex I) of the mitochondrial respiratory chain catalyzes the transfer of electrons from NADH to ubiquinone, and consists of at least 43 subunits. The complex is located in the inner mitochondrial membrane. This gene encodes the 24 kDa subunit of complex I, and is involved in electron transfer. Mutations in this gene are implicated in Parkinson's disease, bipolar disorder, schizophrenia, and have been found in one case of early onset hypertrophic cardiomyopathy and encephalopathy. A non-transcribed pseudogene of this locus is found on chromosome 19. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.578213E-7).
BP6
Variant 18-9117869-T-C is Benign according to our data. Variant chr18-9117869-T-C is described in ClinVar as [Benign]. Clinvar id is 9054.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-9117869-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.837 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NDUFV2NM_021074.5 linkuse as main transcriptc.86T>C p.Val29Ala missense_variant 2/8 ENST00000318388.11 NP_066552.2
NDUFV2XM_017025782.2 linkuse as main transcriptc.-2T>C 5_prime_UTR_variant 2/8 XP_016881271.1
NDUFV2XR_243808.4 linkuse as main transcriptn.131T>C non_coding_transcript_exon_variant 2/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NDUFV2ENST00000318388.11 linkuse as main transcriptc.86T>C p.Val29Ala missense_variant 2/81 NM_021074.5 ENSP00000327268 P1

Frequencies

GnomAD3 genomes
AF:
0.790
AC:
120110
AN:
152030
Hom.:
47658
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.758
Gnomad AMI
AF:
0.794
Gnomad AMR
AF:
0.758
Gnomad ASJ
AF:
0.893
Gnomad EAS
AF:
0.713
Gnomad SAS
AF:
0.858
Gnomad FIN
AF:
0.745
Gnomad MID
AF:
0.883
Gnomad NFE
AF:
0.818
Gnomad OTH
AF:
0.815
GnomAD3 exomes
AF:
0.798
AC:
200495
AN:
251114
Hom.:
80523
AF XY:
0.805
AC XY:
109345
AN XY:
135798
show subpopulations
Gnomad AFR exome
AF:
0.757
Gnomad AMR exome
AF:
0.750
Gnomad ASJ exome
AF:
0.895
Gnomad EAS exome
AF:
0.716
Gnomad SAS exome
AF:
0.859
Gnomad FIN exome
AF:
0.749
Gnomad NFE exome
AF:
0.816
Gnomad OTH exome
AF:
0.820
GnomAD4 exome
AF:
0.813
AC:
1172718
AN:
1442934
Hom.:
478193
Cov.:
30
AF XY:
0.815
AC XY:
585798
AN XY:
719068
show subpopulations
Gnomad4 AFR exome
AF:
0.758
Gnomad4 AMR exome
AF:
0.752
Gnomad4 ASJ exome
AF:
0.896
Gnomad4 EAS exome
AF:
0.656
Gnomad4 SAS exome
AF:
0.862
Gnomad4 FIN exome
AF:
0.751
Gnomad4 NFE exome
AF:
0.819
Gnomad4 OTH exome
AF:
0.819
GnomAD4 genome
AF:
0.790
AC:
120207
AN:
152148
Hom.:
47701
Cov.:
32
AF XY:
0.787
AC XY:
58539
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.759
Gnomad4 AMR
AF:
0.757
Gnomad4 ASJ
AF:
0.893
Gnomad4 EAS
AF:
0.713
Gnomad4 SAS
AF:
0.858
Gnomad4 FIN
AF:
0.745
Gnomad4 NFE
AF:
0.818
Gnomad4 OTH
AF:
0.812
Alfa
AF:
0.814
Hom.:
21804
Bravo
AF:
0.789
TwinsUK
AF:
0.815
AC:
3021
ALSPAC
AF:
0.831
AC:
3203
ESP6500AA
AF:
0.761
AC:
3352
ESP6500EA
AF:
0.819
AC:
7042
ExAC
AF:
0.800
AC:
97097
Asia WGS
AF:
0.720
AC:
2503
AN:
3478
EpiCase
AF:
0.818
EpiControl
AF:
0.824

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mitochondrial complex 1 deficiency, nuclear type 7 Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 05, 2021- -
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsAug 11, 2021- -
not provided Benign:3
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicFeb 19, 2016- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingGeneDxJan 03, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Parkinson disease, mitochondrial Uncertain:1
Uncertain significance, no assertion criteria providedliterature onlyOMIMApr 01, 1998- -
Mitochondrial complex I deficiency, nuclear type 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
7.2
DANN
Benign
0.82
DEOGEN2
Benign
0.11
T;T
Eigen
Benign
-0.91
Eigen_PC
Benign
-0.64
FATHMM_MKL
Benign
0.037
N
LIST_S2
Benign
0.026
T;T
MetaRNN
Benign
7.6e-7
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-1.6
N;.
MutationTaster
Benign
1.0
P;P
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
1.2
N;N
REVEL
Benign
0.11
Sift
Benign
1.0
T;T
Sift4G
Benign
0.78
T;T
Polyphen
0.0
B;.
Vest4
0.070
MPC
0.040
ClinPred
0.0032
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.024
gMVP
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs906807; hg19: chr18-9117867; COSMIC: COSV59186794; COSMIC: COSV59186794; API